Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

23 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Estradiol Transdermal System Articles

Mylan settles with Novartis over Vivelle-Dot; Impax files for generic Fentora

21 November 2011

Schering AG's Menostar approved in the USA

14 June 2004

US FDA's most serious enforcement activities "having unprecedented success"

7 July 2003

Noven tanks as ADHD patch is rejected by US FDA; partner Shire also impacted

5 May 2003

Watson gets US OK on new use for Alora

15 April 2002

Novartis launches new ERT patch in Germany

15 April 2002

Noven Pharma boost from JV revenues

4 March 2002

Low-dose Climara cleared in USA

11 April 2001

Novartis and Noven sign EstradotT deal

9 November 2000

Watson buys back Alora from P&G

11 October 1999

World's smallest HRT patch launched in USA

13 May 1999

US FDA Approves Groupe Fournier's Esclim

12 November 1998

US 2nd Qtr Corporate Results Round-Up

7 August 1997

Alora Launched In USA

30 May 1997

Further Applications Filed For Alora Patch

8 July 1996

Showing 1-15 of 15 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Italy's pharma market slump set to continue, warns GlobalData
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Italy's pharma market slump set to continue, warns GlobalData
  • Is failure to adopt business process management putting the pharma industry at risk?

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS